These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18942197)

  • 1. [Sepsis therapy -- how effective are the therapy strategies?].
    Brunkhorst F; Reinhart K
    Chirurg; 2008 Sep; 79(9):877-8. PubMed ID: 18942197
    [No Abstract]   [Full Text] [Related]  

  • 2. Should we be using activated protein C to treat severe sepsis?
    Eve RL; Duffy MR
    Br J Hosp Med (Lond); 2009 Aug; 70(8):484. PubMed ID: 19684544
    [No Abstract]   [Full Text] [Related]  

  • 3. [Activated protein C, coagulation, inflammation and treatment of severe sepsis].
    van Zanten AR; Bakker J; van den Berg PC; Girbes AR; van Leeuwen SJ
    Ned Tijdschr Geneeskd; 2001 Jun; 145(24):1179. PubMed ID: 11433670
    [No Abstract]   [Full Text] [Related]  

  • 4. [Activated protein C, coagulation, inflammation and treatment of severe sepsis].
    Ott A
    Ned Tijdschr Geneeskd; 2001 Nov; 145(45):2196-7. PubMed ID: 11727624
    [No Abstract]   [Full Text] [Related]  

  • 5. [Activated protein C, coagulation, inflammation and treatment of severe sepsis].
    Bartelink AK; van Deuren M
    Ned Tijdschr Geneeskd; 2001 Jun; 145(24):1178-9. PubMed ID: 11433669
    [No Abstract]   [Full Text] [Related]  

  • 6. Science, medicine and industry: are we getting out of the black hole in sepsis research?
    Suter PM; Takala J
    Intensive Care Med; 2008 Nov; 34(11):1950-4. PubMed ID: 18839139
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant activated protein C in pediatric sepsis.
    Dalton HJ
    Pediatr Infect Dis J; 2003 Aug; 22(8):743-5. PubMed ID: 12913779
    [No Abstract]   [Full Text] [Related]  

  • 8. Once is not enough: clinical trials in sepsis.
    Sweeney DA; Danner RL; Eichacker PQ; Natanson C
    Intensive Care Med; 2008 Nov; 34(11):1955-60. PubMed ID: 18839140
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant human activated protein C in sepsis: inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trials.
    Eichacker PQ; Natanson C
    Crit Care Med; 2003 Jan; 31(1 Suppl):S94-6. PubMed ID: 12544982
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trials for severe sepsis/DIC].
    Kushimoto S
    Rinsho Byori; 2011 Feb; Suppl 147():85-94. PubMed ID: 21761754
    [No Abstract]   [Full Text] [Related]  

  • 11. For sepsis, the drugs don't work.
    Lancet Infect Dis; 2012 Feb; 12(2):89. PubMed ID: 22281132
    [No Abstract]   [Full Text] [Related]  

  • 12. The value of innovation.
    Macias WL; Levy H
    S Afr Med J; 2003 Jul; 93(7):502-3. PubMed ID: 12939918
    [No Abstract]   [Full Text] [Related]  

  • 13. [Surgical patients with severe sepsis: first results of the PROWESS study. Demographic data].
    Montravers P; Blaise M
    Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():38-9. PubMed ID: 15359941
    [No Abstract]   [Full Text] [Related]  

  • 14. A blind clinical evaluation committee should, in theory, make data of a randomized clinical trial stronger, not weaker.
    Carlet J
    Intensive Care Med; 2004 May; 30(5):994; author reply 995. PubMed ID: 15083270
    [No Abstract]   [Full Text] [Related]  

  • 15. [PROWESS--milestone in lowering sepsis mortality].
    Reinhart K
    Krankenpfl J; 2002; 40(10-12):315. PubMed ID: 12600016
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in the management of sepsis: the randomised controlled trials behind the Surviving Sepsis Campaign recommendations.
    Poulton B
    Int J Antimicrob Agents; 2006 Feb; 27(2):97-101. PubMed ID: 16417989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editors' comments on a new trial of activated protein C for persistent septic shock.
    Mancebo J; Antonelli M
    Intensive Care Med; 2008 Nov; 34(11):1948-9. PubMed ID: 18839138
    [No Abstract]   [Full Text] [Related]  

  • 18. [The FDA's questions].
    Opal S
    Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():20-2. PubMed ID: 15359935
    [No Abstract]   [Full Text] [Related]  

  • 19. [PROWESS: description and key results].
    Vallet B
    Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():12-5. PubMed ID: 15359933
    [No Abstract]   [Full Text] [Related]  

  • 20. How to ENHANCE our knowledge of activated protein C during pediatric sepsis trials: pediatric versus adult trials.
    Hazelzet JA
    Pediatr Crit Care Med; 2006 May; 7(3):277-8. PubMed ID: 16682888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.